Corticosteroids and Outcome in Children Undergoing Congenital Heart Surgery: Analysis of the Pediatric Health Information Systems Database

Overview

Journal Circulation

Specialty Cardiology & Vascular Diseases

Date 2010 Nov 10

PMID 21060075

Citations 44

Authors

Sara K Pasquali

Matthew Hall

Jennifer S Li

Eric D Peterson

James Jaggers

Andrew J Lodge

Bradley S Marino

Denise M Goodman

Samir S Shah

Affiliations

Soon will be listed here.

Abstract

Background: Children undergoing congenital heart surgery often receive corticosteroids with the aim of reducing the inflammatory response after cardiopulmonary bypass; however, the value of this approach is unclear.

Methods And Results: The Pediatric Health Information Systems Database was used to evaluate outcomes associated with corticosteroids in children (0 to 18 years of age) undergoing congenital heart surgery at 38 US centers from 2003 to 2008. Propensity scores were constructed to account for potential confounders: age, sex, race, prematurity, genetic syndrome, type of surgery (Risk Adjustment in Congenital Heart Surgery [RACHS-1] category), center, and center volume. Multivariable analysis, adjusting for propensity score and individual covariates, was performed to evaluate in-hospital mortality, postoperative length of stay, duration of ventilation, infection, and use of insulin. A total of 46 730 children were included; 54% received corticosteroids. In multivariable analysis, there was no difference in mortality among corticosteroid recipients and nonrecipients (odds ratio, 1.13; 95% confidence interval, 0.98 to 1.30). Corticosteroids were associated with longer length of stay (least square mean difference, 2.18 days; 95% confidence interval, 1.62 to 2.74 days), greater infection (odds ratio, 1.27; 95% confidence interval, 1.10 to 1.46), and greater use of insulin (odds ratio, 2.45; 95% confidence interval, 2.24 to 2.67). There was no difference in duration of ventilation. In analysis stratified by RACHS-1 category, no significant benefit was seen in any group, and the association of corticosteroids with increased morbidity was most prominent in RACHS-1 categories 1 through 3.

Conclusion: In this observational analysis of children undergoing congenital heart surgery, we were unable to demonstrate a significant benefit associated with corticosteroids and found that corticosteroids may be associated with increased morbidity, particularly in lower-risk patients.

Citing Articles

Congenital Heart Defects and Concurrent Diagnoses in Influenza Hospitalization in the Pediatric Health Information System Study, 2004-2019.

Stephens S, Tsang R, Li R, Cazaban-Ganduglia C, Agopian A, Morris S Pediatr Cardiol. 2024; .

PMID: 39103680 DOI: 10.1007/s00246-024-03613-7.

Using Pharmacokinetic Modeling and Electronic Health Record Data to Predict Clinical and Safety Outcomes after Methylprednisolone Exposure during Cardiopulmonary Bypass in Neonates.

Foote H, Wu H, Balevic S, Thompson E, Hill K, Graham E Congenit Heart Dis. 2023; 18(3):295-313.

PMID: 37484782 PMC: 10361697. DOI: 10.32604/chd.2023.026262.

Broad- Versus Narrow-Spectrum Perioperative Antibiotics and Outcomes in Pediatric Congenital Heart Disease Surgery: Analysis of the Vizient Clinical Data Base.

Cooch P, Kim M, Swami N, Tamma P, Tabbutt S, Steurer M J Pediatric Infect Dis Soc. 2023; 12(4):205-213.

PMID: 37018466 PMC: 10146935. DOI: 10.1093/jpids/piad022.

Methylprednisolone in Pediatric Cardiac Surgery: Is There Enough Evidence?.

van Saet A, Zeilmaker-Roest G, Stolker R, Bogers A, Tibboel D Front Cardiovasc Med. 2021; 8:730157.

PMID: 34631828 PMC: 8492975. DOI: 10.3389/fcvm.2021.730157.

Steroids in paediatric heart surgery: eminence or evidence-based practice?.

Fudulu D, Lightman S, Caputo M, Angelini G Indian J Thorac Cardiovasc Surg. 2020; 34(4):483-487.

PMID: 33060920 PMC: 7525744. DOI: 10.1007/s12055-018-0670-y.

References

Jacobs J, Jacobs M, Lacour-Gayet F, Jenkins K, Gauvreau K, Bacha E . Stratification of complexity improves the utility and accuracy of outcomes analysis in a Multi-Institutional Congenital Heart Surgery Database: Application of the Risk Adjustment in Congenital Heart Surgery (RACHS-1) and Aristotle Systems in the.... Pediatr Cardiol. 2009; 30(8):1117-30. DOI: 10.1007/s00246-009-9496-0. View

Ho K, Tan J . Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis. Circulation. 2009; 119(14):1853-66. DOI: 10.1161/CIRCULATIONAHA.108.848218. View

Brix-Christensen V . The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children. Acta Anaesthesiol Scand. 2001; 45(6):671-9. DOI: 10.1034/j.1399-6576.2001.045006671.x. View

Boyle Jr E, Pohlman T, Johnson M, Verrier E . Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg. 1997; 63(1):277-84. DOI: 10.1016/s0003-4975(96)01061-2. View

Welke K, Diggs B, Karamlou T, Ungerleider R . Comparison of pediatric cardiac surgical mortality rates from national administrative data to contemporary clinical standards. Ann Thorac Surg. 2008; 87(1):216-22. DOI: 10.1016/j.athoracsur.2008.10.032. View

Varan B, Tokel K, Mercan S, Donmez A, Aslamaci S . Systemic inflammatory response related to cardiopulmonary bypass and its modification by methyl prednisolone: high dose versus low dose. Pediatr Cardiol. 2002; 23(4):437-41. DOI: 10.1007/s00246-002-0118-3. View

Checchia P, Karamlou T, Maruszewski B, Ohye R, Bronicki R, Dodge-Khatami A . Haematological and infectious complications associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease. Cardiol Young. 2008; 18 Suppl 2:226-33. DOI: 10.1017/S1047951108002965. View

Jansen N, van Oeveren W, van Vliet M, Stoutenbeek C, Eysman L, Wildevuur C . The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass. Eur J Cardiothorac Surg. 1991; 5(4):211-7. DOI: 10.1016/1010-7940(91)90032-f. View

Duval E, Kavelaars A, Veenhuizen L, Van Vught A, van de Wal H, Heijnen C . Pro- and anti-inflammatory cytokine patterns during and after cardiac surgery in young children. Eur J Pediatr. 1999; 158(5):387-93. DOI: 10.1007/s004310051098. View

10.

Lindberg L, Forsell C, Jogi P, Olsson A . Effects of dexamethasone on clinical course, C-reactive protein, S100B protein and von Willebrand factor antigen after paediatric cardiac surgery. Br J Anaesth. 2003; 90(6):728-32. DOI: 10.1093/bja/aeg125. View

11.

BENZING 3rd G, Francis P, Kaplan S, HELMSWORTH J, Sperling M . Glucose and insulin changes in infants and children undergoing hypothermic open-heart surgery. Am J Cardiol. 1983; 52(1):133-6. DOI: 10.1016/0002-9149(83)90083-8. View

12.

Holzmann-Pazgal G, Hopkins-Broyles D, Recktenwald A, Hohrein M, Kieffer P, Huddleston C . Case-control study of pediatric cardiothoracic surgical site infections . Infect Control Hosp Epidemiol. 2008; 29(1):76-9. DOI: 10.1086/524323. View

13.

Schroeder V, Pearl J, Schwartz S, Shanley T, Manning P, Nelson D . Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces postbypass inflammatory mediator expression. Circulation. 2003; 107(22):2823-8. DOI: 10.1161/01.CIR.0000070955.55636.25. View

14.

Elliott M . Ultrafiltration and modified ultrafiltration in pediatric open heart operations. Ann Thorac Surg. 1993; 56(6):1518-22. DOI: 10.1016/0003-4975(93)90744-3. View

15.

Sturmer T, Joshi M, Glynn R, Avorn J, Rothman K, Schneeweiss S . A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol. 2006; 59(5):437-47. PMC: 1448214. DOI: 10.1016/j.jclinepi.2005.07.004. View

16.

Andreasson S, Gothberg S, Berggren H, Bengtsson A, Eriksson E, Risberg B . Hemofiltration modifies complement activation after extracorporeal circulation in infants. Ann Thorac Surg. 1993; 56(6):1515-7. DOI: 10.1016/0003-4975(93)90743-2. View

17.

Lodge A, Chai P, Daggett C, Ungerleider R, Jaggers J . Methylprednisolone reduces the inflammatory response to cardiopulmonary bypass in neonatal piglets: timing of dose is important. J Thorac Cardiovasc Surg. 1999; 117(3):515-22. DOI: 10.1016/s0022-5223(99)70331-4. View

18.

Friedrich B, Schmidt R, Reiss I, Gunther A, Seeger W, Muller M . Changes in biochemical and biophysical surfactant properties with cardiopulmonary bypass in children. Crit Care Med. 2003; 31(1):284-90. DOI: 10.1097/00003246-200301000-00045. View

19.

Bronicki R, Backer C, Baden H, Mavroudis C, Crawford S, Green T . Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg. 2000; 69(5):1490-5. DOI: 10.1016/s0003-4975(00)01082-1. View

20.

Teoh K, Bradley C, Gauldie J, Burrows H . Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery. Circulation. 1995; 92(9 Suppl):II347-53. DOI: 10.1161/01.cir.92.9.347. View